Evidence map›Paper›PMID 36406113›Full record

ArticleFrontiers in genetics2022

Establishing a database for sickle cell disease patient mapping and survival tracking: The sickle pan-african research consortium Nigeria example.

Obiageli Nnodu, Anazoeze Madu, Reuben Chianumba, Hezekiah Alkali Isa, Isaac Olanrewaju, Samuel Osagie, Nash Oyekanmi, Raphael Zozimus Sangeda, Annemie Stewart, Victoria Nembaware and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Obiageli NnoduCentre of Excellence for Sickle Cell Disease Research and Training (CESRTA), University of Abuja, Abuja, Nigeria.
Anazoeze MaduDepartment of Haematology and Immunology, College of Medicine, University of Nigeria, Enugu, Nigeria.
Reuben ChianumbaDepartment of Haematology and Blood Transfusion, University of Abuja, Abuja, Nigeria.
Hezekiah Alkali IsaCentre of Excellence for Sickle Cell Disease Research and Training (CESRTA), University of Abuja, Abuja, Nigeria.
Isaac OlanrewajuDepartment of Computer Science, University of Abuja, Abuja, Nigeria.
Samuel OsagieITMS Unit, University of Abuja, Abuja, Nigeria.
Nash OyekanmiH3Africa Bioinformatics Network (H3ABioNet) Node, Centre for Genomics Research and Innovation, Abuja, Nigeria.
Raphael Zozimus SangedaDepartment of Pharmaceutical Microbiology, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.
Annemie StewartUCT Clinical Research Centre, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Victoria NembawareComputational Biology Division, IDM, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Jack MorriceDivision of Human Genetics, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Mario JonasFaculty of Health Sciences, Department of Pathology, Division of Human Genetics, University of Cape Town, Cape Town, South Africa.
Gaston MazanduComputational Biology Division, IDM, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Ambroise WonkamDepartment of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Olumide OwolabiCentre of Excellence for Sickle Cell Disease Research and Training (CESRTA), University of Abuja, Abuja, Nigeria.

Funding

Sickle Pan African Research Consortium NigEria (SPARC-NEt)U01HL156942 · NHLBI · UNIVERSITY OF ABUJA · PI NNODU, OBIAGELI EUNICE · 2021 to 2025
$1.3M
NHLBI NIH HHS U01 HL156942
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

databaseNigeriaREDCapregistrysickle cell diseaseSPARCO

Identifiers

PMID36406113
PMCPMC9672677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.